NTQ5082

· Nanjing Chia-tai Tianqing Pharmaceutical

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NTQ5082, covering 2024-08-19 to 2025-09-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients [Phase 3]